Literature DB >> 19563617

Expression of ADAM-15 in rat myocardial infarction.

Ji Ke Li1, Wen Juan Du, Shu Lin Jiang, Hai Tian.   

Abstract

A disintegrin and metalloprotease-15 (ADAM-15) is a potential novel regulator of inflammatory response and tissue remodelling, which is thought to have the ability to attenuate the cardiac function resulting from myocardial infarction (MI). Therefore, the aim of our study was to investigate the expression of ADAM-15 in rat MI. Wistar rats were subjected to MI by ligation of the left anterior descending coronary artery. Euthanasia was performed at 1, 3, 7 and 14 days following MI. The mRNA and protein expression levels of ADAM-15 were detected respectively by reverse transcription-polymerase chain reaction (RT-PCR) and Western blot. The localization of ADAM-15 protein was observed by immunohistochemistry. Compared with sham-MI, the expression of ADAM-15 in MI increased at day 1, reached to maximum at day 3, decreased at day 7 and day 14 gradually. In addition, we also found that the localization of ADAM-15 was mainly at cardiac myocytes in the border area of MI and some macrophages in the border and infarcted areas. This study revealed a significant difference of ADAM-15 expression in rat MI and indicated that ADAM-15 maybe one of the important factors involved in inflammatory response and cardiac remodelling of rat MI.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19563617      PMCID： PMC2697557          DOI： 10.1111/j.1365-2613.2009.00642.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN： 0959-9673            Impact factor:   1.925


  41 in total

1.  Interaction of the metalloprotease disintegrins MDC9 and MDC15 with two SH3 domain-containing proteins, endophilin I and SH3PX1.

Authors:  L Howard; K K Nelson; R A Maciewicz; C P Blobel
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

2.  RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction.

Authors:  K Eto; W Puzon-McLaughlin; D Sheppard; A Sehara-Fujisawa; X P Zhang; Y Takada
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

3.  Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions.

Authors:  Koji Eto; Clotilde Huet; Takehiko Tarui; Sergey Kupriyanov; Hai-Zhen Liu; Wilma Puzon-McLaughlin; Xi-Ping Zhang; Dean Sheppard; Eva Engvall; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2002-03-06       Impact factor: 5.157

Review 4.  Matrix metalloproteinases: regulation and dysregulation in the failing heart.

Authors:  Francis G Spinale
Journal:  Circ Res       Date:  2002-03-22       Impact factor: 17.367

5.  Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure.

Authors:  Shaw-Yung Shai; Alice E Harpf; Christopher J Babbitt; Maria C Jordan; Michael C Fishbein; Ju Chen; Michelle Omura; Tarek A Leil; K David Becker; Meisheng Jiang; Desmond J Smith; Simon R Cherry; Joseph C Loftus; Robert S Ross
Journal:  Circ Res       Date:  2002-03-08       Impact factor: 17.367

6.  Ten year mortality in subsets of patients with an acute coronary syndrome.

Authors:  J Herlitz; B W Karlson; M Sjölin; J Lindqvist
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

7.  Phosphorylation-dependent interactions between ADAM15 cytoplasmic domain and Src family protein-tyrosine kinases.

Authors:  Zaruhi Poghosyan; Stephen M Robbins; Miles D Houslay; Ailsa Webster; Gillian Murphy; Dylan R Edwards
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

8.  The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone.

Authors:  D R McCulloch; M Harvey; A C Herington
Journal:  Mol Cell Endocrinol       Date:  2000-09-25       Impact factor: 4.102

9.  Altered expression of ADAMs (A Disintegrin And Metalloproteinase) in fibrillating human atria.

Authors:  Marco Arndt; Uwe Lendeckel; Christoph Röcken; Karen Nepple; Carmen Wolke; Antje Spiess; Christof Huth; Siegfried Ansorge; Helmut U Klein; Andreas Goette
Journal:  Circulation       Date:  2002-02-12       Impact factor: 29.690

10.  TIMP-3 deficiency leads to dilated cardiomyopathy.

Authors:  Paul W M Fedak; David S Smookler; Zamaneh Kassiri; Nobuhisa Ohno; Kevin J Leco; Subodh Verma; Donald A G Mickle; Katrina L Watson; Carlo V Hojilla; William Cruz; Richard D Weisel; Ren-Ke Li; Rama Khokha
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690
View more
  4 in total

1.  ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

Authors:  HaiFeng Yang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2022-01-24

2.  Cardiac structural and hemodynamic changes associated with physiological heart hypertrophy of pregnancy are reversed postpartum.

Authors:  Soban Umar; Rangarajan Nadadur; Andrea Iorga; Marjan Amjedi; Humann Matori; Mansoureh Eghbali
Journal:  J Appl Physiol (1985)       Date:  2012-08-23

3.  Reverse right ventricular structural and extracellular matrix remodeling by estrogen in severe pulmonary hypertension.

Authors:  Rangarajan D Nadadur; Soban Umar; Gabriel Wong; Mansour Eghbali; Andrea Iorga; Humann Matori; Rod Partow-Navid; Mansoureh Eghbali
Journal:  J Appl Physiol (1985)       Date:  2012-05-24

4.  ADAM15 expression is increased in lung CD8+ T cells, macrophages, and bronchial epithelial cells in patients with COPD and is inversely related to airflow obstruction.

Authors:  Xiaoyun Wang; Duo Zhang; Andrew Higham; Sophie Wolosianka; Xiaoyan Gai; Lu Zhou; Hans Petersen; Victor Pinto-Plata; Miguel Divo; Edwin K Silverman; Bartolome Celli; Dave Singh; Yongchang Sun; Caroline A Owen
Journal:  Respir Res       Date:  2020-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.